RNAC
NASDAQ · Biotechnology
Cartesian Therapeutics Inc
$6.43
+0.28 (+4.55%)
Open$6.18
Previous Close$6.15
Day High$6.50
Day Low$6.15
52W High$15.96
52W Low$5.98
Volume—
Avg Volume132.0K
Market Cap161.17M
P/E Ratio—
EPS$-5.02
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+532.3% upside
Current
$6.43
$6.43
Target
$40.66
$40.66
$22.44
$40.66 avg
$45.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.08M | 10.49M | 132.93M |
| Net Income | -143,365,618 | -439,771,834 | 3.48M |
| Profit Margin | -4,658.6% | -4,425.7% | 2.6% |
| EBITDA | -157,462,704 | -509,848,564 | 5.52M |
| Free Cash Flow | — | — | 2.68M |
| Rev Growth | -70.7% | -70.7% | -1.8% |
| Debt/Equity | 0.28 | 0.28 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |